Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-10-23
2007-10-23
Kemmerer, Elizabeth C. (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S007210, C435S007800, C436S501000, C436S503000
Reexamination Certificate
active
10878773
ABSTRACT:
The present invention relates to methods for identifying agents that modulate the effect of cytokine class I receptor binding compounds, by inhibiting the interaction between the cytokine class I receptor and nuclear factors. The agents are useful for decreasing IGF-1 levels in a cell, and for the treatment of medical disorders caused by hormone dysregulation, such as growth hormone or prolactin dysregulation.
REFERENCES:
patent: WO 98/41872 (1998-09-01), None
patent: WO 00/52153 (2000-09-01), None
patent: WO 00/66632 (2000-11-01), None
patent: WO 03/031651 (2003-04-01), None
Phosphorylation. Wikipedia website. wikipedia.org/wiki/Phosphorylation; accessed Jun. 2, 2006; pp. 1-2.
Ozaki et al., JBC. 2002; 277: 29355-29358.
sigma-aldrich.com/ehandbook, Cytokine Receptors (Hematopoeitin Receptor Family, pp. 174-179.
Denson et al., J Clin Invest. 107:1451-1458, Jul. 27, 2007.
Ram et al., J Biol Chem. 1996; 271: 5929-5940.
Adams, Biochem J. 1999; 344: 867-872.
Bichell, D.P., Kikuchi, K., Rotwein, P. (1992). Growth Hormone Rapidly Activates Insulin-Like Growth Factor I Gene Transcription in vivo.Mol. Endocrin. 6:1899-1908.
Bromberg (2000). Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development.Breast Cancer2:86-90.
Catlett-Falcone et al., (1999). STAT proteins as novel targets for cancer therapy.Current Opinion in Oncology11:490-496.
Clevenger, C.V., Furth, P., Hankinson, S.E., Shuler, L. (2003). The role of prolactin in mammary carcinoma.Endocrine Rev. 24:1-27.
Dignam, J.D., Lebowitz, R. M., Roeder, R. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.Nucl. Acids Res. 11:1475-1489.
Graichen, R., Sandstedt, J., Goh, E. L. K., Isaksson, O. G. P., Törnell, J., Lobie, P. E. (2003). the Growth Hormone-binding Protein Is a Location-dependent Cytokine Receptor Transcriptional Enhancer.J. Biol. Chem. 278:6346-6354.
Helander, H., Gustafsson, J-Å., Mode, A. (2002). Possible involvement of truncated signal transducer and activator of transcription-5 in the GH pattern-dependent regulation of CYP2C12 gene expression in rat liver.Mol. Endocrinology16:1598-1611.
Horvath (2000). STAT proteins and transcriptional responses to extracellular signals.TIBS25:496-501.
Jiang, L.-W., Schindler, M. (1990). Nucloecytoplasmic transport is enhanced concomitant with nuclear accumulation of epidermal growth factor (EGF) binding activity in both 3T3-1 and EGF receptor reconstituted NR-6 fibroblasts.J. Cell Biol. 110:559-568.
Johnson et al., (2001). Differential expression of suppressors of cytokine signaling genes in response to nutrition and growth hormone in the septic rat.Journal of Endocrinology169:409-415.
Le Stunff, C., Thomas, M. J., Rotwein, P. (1995). Rapid Activation of Rat Insulin-Like Growth Factor-I Gene Transcription by Growth Hormone Reveals No Changes in Deoxyribonucleic Acid-Protein Interactions within the Second Promoter.Endocrinology136:2230-2237.
Lobie, P. E., Wood, T. J. J., Chen, C. M., Waters, M. J., Norstedt, G. (1994). Nuclear Translocation and Anchorage of the Growth Hormone Receptor.J. Biol. Chem.269:31735-31746.
Nolten, L.A., Steenbergh, P.H., Sussenbach, J.S. (1995). Hepatocyte nuclear factor 1α activates promoter 1 of the human insulin-like growth factor 1 gene via two distinct binding sites.Mol. Endocrinology9: 1488-1499.
Pfisterer, P., Ehlermann, J., Hegen, M., Schorle, H. (2002). A Subtractive Gene Expression Screen Suggests a Role of Transcription Factor AP-2α in Control of Proliferation and Differentiation.J. Biol. Chem.277:6637-6644.
Podlecki, D.A, Smith, R.M., Kao, M., Tsa, M., Huecksteadt, T., Brandenburg, D., Lasher, R.S., Jarret, L., Olefsky, J.M. (1987). Nuclear translocation of the insulin receptor.J. Biol. Chem.262:3362-3368.
Thomas, et al., (1994) Rapid activation of rat insulin-like growth factor-1 gene transcription by growth hormone reveals no alterations in deoxyribonucleic acid-protein interactions within the major promoter.Endocrinology135:1584-1592.
Wang et al., (1997). Characterization of the rat insulin-like growth factor I gene promoters and identification of a minimal exon 2 promoter 1.Endocrinology138(4):1528-1536.
Werling, U., Schorle, H. (2002). Transcription Factor geneAP-2γEssential for Early Murine Development.Mol. Cell. Biol.22:3149-3156.
Zhang, Y., Guan, R., Jiang, J., Kopchick, J.J., Black, R.A., Baumann, G., Frank, S. (2001). Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis.J. Biol. Chem.276: 24565-24573.
Moréus Lotta
Parrow Vendela
Biovitrum AB
Borgeest Christina
Fish & Richardson P.C.
Kemmerer Elizabeth C.
LandOfFree
Methods for identifying active compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for identifying active compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for identifying active compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3888627